Facebook-f Twitter Linkedin-in
November 15, 2024
  1. Home
  2. Industry
  3. Pharma and Healthcare
  4. WuXi Bio, InnoCare tap equity investors for…
Pharma and Healthcare Software and Hi-Tech

WuXi Bio, InnoCare tap equity investors for HK$16bn

  • February 3, 2021
  • 3
  • 1 minute read

Chinese biopharmaceutical duo WuXi Biologics (Cayman) and InnoCare Pharma raised a combined HK$16.2bn ($2.1bn) on Tuesday from selling new stock.

Read Previous

Nomura posts record investment banking results
Read Next

China Industrial Securities bags $300m

Most Popular

Angel / Venture
Discover the top drone startups that are making waves in the industry and attracting significant investments from private equity firms

Emerging Drone Startups to watch for in 2023

May 10, 2023
Event

Sinic sells $210m bond with first-time ratings in hand

June 12, 2020
Angel / Venture
Discover leading PE & VC companies investing in the drone industry, including MavensWood Investment Ltd. and its portfolio company AerialBuz

Top Drone Investors: PE/VC Companies Funding the Drone Industry

May 9, 2023
crypto

Ravencoin Mining Economics

September 5, 2023
Podcasts

Episode 3 – Current State of IT Diligence

August 19, 2017
Podcasts

Episode 4 – Deeeeeeep Dive IT Diligence

August 24, 2017
Podcasts

Episode 5 – The Importance of Visual Design and User Experience

September 5, 2017
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies